Inhibikase Therapeutics is a company focused on developing and commercializing small-molecule kinase inhibitor therapeutics for the safe and effective treatment of neurological diseases inside and outside of the brain, on developing technologies to improve the efficiency of drug delivery and drug penetration of kinase inhibitor therapies inside and outside of the brain and focused on developing novel strategies for the treatme...
Inhibikase Therapeutics is a company focused on developing and commercializing small-molecule kinase inhibitor therapeutics for the safe and effective treatment of neurological diseases inside and outside of the brain, on developing technologies to improve the efficiency of drug delivery and drug penetration of kinase inhibitor therapies inside and outside of the brain and focused on developing novel strategies for the treatment of neurological infections. Our proprietary Re-engineering Approach with Metabolism Preserved (RAMP™) drug innovation engine enables us to design and develop novel small-molecule product candidates.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.